Tetracycline in preventing skin rash in patients who are receiving drugs such as gefitinib and cetuximab for cancer

Journal of Drugs in Dermatology, July-August, 2005

This study is currently recruiting patients. Sponsors and collaborators: North Central Cancer Treatment Group. This randomized clinical trial is studying tetracycline to see how well it works compared to placebo in preventing skin rash in patients who are receiving drugs such as gefitinib or cetuximab for cancer.

Condition          Treatment or Intervention

Unspecified adult  Drug: tetracycline
solid tumor,       Procedure: complications of therapy ssessment/
protocol specific    management
                   Procedure: dermatologic complications management
                   Procedure: supportive care/therapy

Study ID Numbers: CDR0000385682; NCCTG-N03CB; NCT00091247

ClinicalTrials.gov Identifier: NCT00091247